---
figid: PMC8962344__biomedicines-10-00481-g002
figtitle: Considerations about Hypoxic Changes in Neuraxis Tissue Injuries and Recovery
organisms:
- NA
pmcid: PMC8962344
filename: biomedicines-10-00481-g002.jpg
figlink: /pmc/articles/PMC8962344/figure/biomedicines-10-00481-f002/
number: F2
caption: The cellular mechanism of hypoxia (showing how oxygen partial pressure, pO2,
  influences deoxynucleic acid, DNA, via hypoxia-inducible factor, HIF; with involvement
  of factor inhibiting HIF, FIH; arginine, ARG; C-terminal transactivation domain,
  CAD; protein 300, p300 and Von Hipple-Lindau factor, VHL and proline hydroxylase,
  PHD. We can see how hypoxia response elements (HRE) are activated, as the atypical
  Nuclear Factor kB, NF-kB, activation pathway, with involvement of inhibitor kB,
  I-kb. This triggers the genes of lactate dehydrogenase A, LDH-A; adenylate kinase
  3, AK-3; aldolase A, ALD-A; phosphoglycerate kinase 1, PGK-1; phosphofructokinase,
  liver type, PFK-L 6; vascular endothelial growth factor, VEGF; erythropoietin, EPO;
  glucose transporter 1, Glut-1; interleukin 8, IL 8; B cell lymphoma-2, Bcl-2; matrix
  metalloproteases, MMP; stromal cell-derived factor 1, SDF).
papertitle: Considerations about Hypoxic Changes in Neuraxis Tissue Injuries and Recovery.
reftext: Simona Isabelle Stoica, et al. Biomedicines. 2022 Feb;10(2):481.
year: '2022'
doi: 10.3390/biomedicines10020481
journal_title: Biomedicines
journal_nlm_ta: Biomedicines
publisher_name: MDPI
keywords: hypoxia | ischemia | neuraxis | hypoxic-ischemic injuries | neural ischemia
  | neural tissue hypoxic injuries | neuro-recovery | neurorehabilitation
automl_pathway: 0.8543297
figid_alias: PMC8962344__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8962344__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8962344__biomedicines-10-00481-g002.html
  '@type': Dataset
  description: The cellular mechanism of hypoxia (showing how oxygen partial pressure,
    pO2, influences deoxynucleic acid, DNA, via hypoxia-inducible factor, HIF; with
    involvement of factor inhibiting HIF, FIH; arginine, ARG; C-terminal transactivation
    domain, CAD; protein 300, p300 and Von Hipple-Lindau factor, VHL and proline hydroxylase,
    PHD. We can see how hypoxia response elements (HRE) are activated, as the atypical
    Nuclear Factor kB, NF-kB, activation pathway, with involvement of inhibitor kB,
    I-kb. This triggers the genes of lactate dehydrogenase A, LDH-A; adenylate kinase
    3, AK-3; aldolase A, ALD-A; phosphoglycerate kinase 1, PGK-1; phosphofructokinase,
    liver type, PFK-L 6; vascular endothelial growth factor, VEGF; erythropoietin,
    EPO; glucose transporter 1, Glut-1; interleukin 8, IL 8; B cell lymphoma-2, Bcl-2;
    matrix metalloproteases, MMP; stromal cell-derived factor 1, SDF).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HIF1A
  - PDC
  - VHL
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - CASR
  - ABL2
  - RERE
  - CAD
  - DFFB
  - ACOD1
  - NFKB1
  - EP300
  - LDHA
  - AK3
  - AK4
  - ALDOA
  - PGK1
  - PFKM
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - EPO
  - TIMP1
  - EPX
  - SLC2A1
  - BCL2
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
---
